Compare $LSTA vs $TOVX | Chartloom

Compare

$LSTA vs $TOVX

Lisata Therapeutics Inc · Theriva Biologics Inc

LSTA

Lisata Therapeutics Inc

TOVX

Theriva Biologics Inc

Compare $LSTA vs $TOVX

Comparing Lisata Therapeutics Inc and Theriva Biologics Inc

LSTALisata Therapeutics Inc

TOVXTheriva Biologics Inc

LSTALisata Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-90.7%

YTD performance

-45.9%

52W performance

-58.1%

FCF yield

-127.6%

TOVXTheriva Biologics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-16.5%

52W performance

-51.8%

FCF yield

-128.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LSTA

TOVX

Detailed metrics comparison

LSTA

Lisata Therapeutics Inc

TOVX

Theriva Biologics Inc

Market Cap

LSTA$10M

TOVX$10M

Enterprise Value

LSTA$-786K

TOVX$275K

Price

LSTA$1.06

TOVX$0.22

P/E Ratio

LSTAN/A

TOVXN/A

P/S Ratio

LSTA96.57x

TOVX33.19x

EV/Sales

LSTA-7.86x

TOVX0.92x

EV/EBITDA

LSTA0.00x

TOVX0.00x

P/B Ratio

LSTA1.61x

TOVX0.85x

P/FCF Ratio

LSTAN/A

TOVXN/A

EV/FCF

LSTA0.06x

TOVX-0.02x

PEG Ratio

LSTAN/A

TOVXN/A

Forward P/E (NTM)

LSTAN/A

TOVXN/A

Forward P/S (NTM)

LSTAN/A

TOVXN/A

Revenue (TTM)

LSTA$100K

TOVX$300K

Revenue Growth (YoY)

LSTA-90.7%

TOVXN/A

Forward Rev Growth

LSTA44.0%

TOVX20375.2%

Gross Margin (TTM)

LSTA9.5%

TOVX71.5%

Operating Margin (TTM)

LSTA0.0%

TOVX0.0%

EBITDA Margin (TTM)

LSTA-11423.0%

TOVX-3940.7%

Net Margin (TTM)

LSTA-10132.0%

TOVX-4376.0%

FCF Margin (TTM)

LSTA-12323.0%

TOVX-4254.7%

Net Income (TTM)

LSTA$-10M

TOVX$-13M

FCF (TTM)

LSTA$-12M

TOVX$-13M

EPS (TTM)

LSTA-$1.11

TOVX-$0.29

ROE (TTM)

LSTA-7510.0%

TOVX-9349.0%

ROA (TTM)

LSTA-6015.0%

TOVX-3269.0%

ROIC (TTM)

LSTA-7510.0%

TOVX-8231.0%

Cash

LSTA$10M

TOVX$11M

Debt

LSTA$0

TOVX$2M

Net Cash/Debt

LSTA$10M

TOVX$10M

Current Ratio (TTM)

LSTA3.69x

TOVX1.13x

Quick Ratio (TTM)

LSTA3.50x

TOVX1.09x

Debt/Equity (TTM)

LSTA0.00x

TOVX0.14x

Debt/Assets (TTM)

LSTA0.0%

TOVX0.0%

Interest Coverage (TTM)

LSTAN/A

TOVXN/A

Net Debt/EBITDA (TTM)

LSTA0.00x

TOVX0.00x

Beta

LSTA0.97

TOVX1.25

52W Performance

LSTA-58.1%

TOVX-51.8%

YTD Performance

LSTA-45.9%

TOVX-16.5%

% from 52W High

LSTA-79.1%

TOVX-74.8%

% from 52W Low

LSTA7.3%

TOVX35.6%

Asset Turnover (TTM)

LSTA0.01x

TOVX0.01x

FCF Yield (TTM)

LSTA-127.6%

TOVX-128.2%

Earnings Yield (TTM)

LSTA-104.9%

TOVX-131.8%

Dividend Yield (TTM)

LSTAN/A

TOVXN/A

Rule of 40

LSTA-12,413.7

TOVX-4,254.7

EV/GP/RG

LSTAN/A

TOVX0.00

Ticker research

View LSTA research View TOVX research

Metric	LSTA Lisata Therapeutics Inc	TOVX Theriva Biologics Inc
Market & Valuation
Market Cap	$10M	$10M
Enterprise Value	$-786K	$275K
Price	$1.06	$0.22
P/E Ratio	N/A	N/A
P/S Ratio	96.57x	33.19x
EV/Sales	-7.86x	0.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.61x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	0.06x	-0.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$100K	$300K
Revenue Growth (YoY)	-90.7%	N/A
Forward Rev Growth	44.0%	20375.2%
Profitability
Gross Margin (TTM)	9.5%	71.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11423.0%	-3940.7%
Net Margin (TTM)	-10132.0%	-4376.0%
FCF Margin (TTM)	-12323.0%	-4254.7%
Net Income (TTM)	$-10M	$-13M
FCF (TTM)	$-12M	$-13M
EPS (TTM)	-$1.11	-$0.29
ROE (TTM)	-7510.0%	-9349.0%
ROA (TTM)	-6015.0%	-3269.0%
ROIC (TTM)	-7510.0%	-8231.0%
Financial Health
Cash	$10M	$11M
Debt	$0	$2M
Net Cash/Debt	$10M	$10M
Current Ratio (TTM)	3.69x	1.13x
Quick Ratio (TTM)	3.50x	1.09x
Debt/Equity (TTM)	0.00x	0.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	1.25
52W Performance	-58.1%	-51.8%
YTD Performance	-45.9%	-16.5%
% from 52W High	-79.1%	-74.8%
% from 52W Low	7.3%	35.6%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.01x
FCF Yield (TTM)	-127.6%	-128.2%
Earnings Yield (TTM)	-104.9%	-131.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-12,413.7	-4,254.7
EV/GP/RG	N/A	0.00
Ticker research	View LSTA research	View TOVX research

Valuation

P/S Ratio

TOVX

33.19x

LSTA

96.57x

EV/FCF

TOVX

-0.02x

LSTA

0.06x

Growth & revenue

Revenue Growth TTM

LSTA

-90.7%

Forward Revenue Growth

TOVX

20375.2%

LSTA

44.0%

Profitability & performance

Gross Margin

TOVX

71.5%

LSTA

9.5%

ROE

LSTA

-7510.0%

TOVX

-9349.0%

FCF Yield %

LSTA

-127.6%

TOVX

-128.2%

52-Week Performance

TOVX

-51.8%

LSTA

-58.1%

Detailed metrics comparison

LSTA

Lisata Therapeutics Inc

TOVX

Theriva Biologics Inc

Market Cap

LSTA$10M

TOVX$10M

Enterprise Value

LSTA$-786K

TOVX$275K

Price

LSTA$1.06

TOVX$0.22

P/E Ratio

LSTAN/A

TOVXN/A

P/S Ratio

LSTA96.57x

TOVX33.19x

EV/Sales

LSTA-7.86x

TOVX0.92x

EV/EBITDA

LSTA0.00x

TOVX0.00x

P/B Ratio

LSTA1.61x

TOVX0.85x

P/FCF Ratio

LSTAN/A

TOVXN/A

EV/FCF

LSTA0.06x

TOVX-0.02x

PEG Ratio

LSTAN/A

TOVXN/A

Forward P/E (NTM)

LSTAN/A

TOVXN/A

Forward P/S (NTM)

LSTAN/A

TOVXN/A

Revenue (TTM)

LSTA$100K

TOVX$300K

Revenue Growth (YoY)

LSTA-90.7%

TOVXN/A

Forward Rev Growth

LSTA44.0%

TOVX20375.2%

Gross Margin (TTM)

LSTA9.5%

TOVX71.5%

Operating Margin (TTM)

LSTA0.0%

TOVX0.0%

EBITDA Margin (TTM)

LSTA-11423.0%

TOVX-3940.7%

Net Margin (TTM)

LSTA-10132.0%

TOVX-4376.0%

FCF Margin (TTM)

LSTA-12323.0%

TOVX-4254.7%

Net Income (TTM)

LSTA$-10M

TOVX$-13M

FCF (TTM)

LSTA$-12M

TOVX$-13M

EPS (TTM)

LSTA-$1.11

TOVX-$0.29

ROE (TTM)

LSTA-7510.0%

TOVX-9349.0%

ROA (TTM)

LSTA-6015.0%

TOVX-3269.0%

ROIC (TTM)

LSTA-7510.0%

TOVX-8231.0%

Cash

LSTA$10M

TOVX$11M

Debt

LSTA$0

TOVX$2M

Net Cash/Debt

LSTA$10M

TOVX$10M

Current Ratio (TTM)

LSTA3.69x

TOVX1.13x

Quick Ratio (TTM)

LSTA3.50x

TOVX1.09x

Debt/Equity (TTM)

LSTA0.00x

TOVX0.14x

Debt/Assets (TTM)

LSTA0.0%

TOVX0.0%

Interest Coverage (TTM)

LSTAN/A

TOVXN/A

Net Debt/EBITDA (TTM)

LSTA0.00x

TOVX0.00x

Beta

LSTA0.97

TOVX1.25

52W Performance

LSTA-58.1%

TOVX-51.8%

YTD Performance

LSTA-45.9%

TOVX-16.5%

% from 52W High

LSTA-79.1%

TOVX-74.8%

% from 52W Low

LSTA7.3%

TOVX35.6%

Asset Turnover (TTM)

LSTA0.01x

TOVX0.01x

FCF Yield (TTM)

LSTA-127.6%

TOVX-128.2%

Earnings Yield (TTM)

LSTA-104.9%

TOVX-131.8%

Dividend Yield (TTM)

LSTAN/A

TOVXN/A

Rule of 40

LSTA-12,413.7

TOVX-4,254.7

EV/GP/RG

LSTAN/A

TOVX0.00

Ticker research

View LSTA research View TOVX research

Metric	LSTA Lisata Therapeutics Inc	TOVX Theriva Biologics Inc
Market & Valuation
Market Cap	$10M	$10M
Enterprise Value	$-786K	$275K
Price	$1.06	$0.22
P/E Ratio	N/A	N/A
P/S Ratio	96.57x	33.19x
EV/Sales	-7.86x	0.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.61x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	0.06x	-0.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$100K	$300K
Revenue Growth (YoY)	-90.7%	N/A
Forward Rev Growth	44.0%	20375.2%
Profitability
Gross Margin (TTM)	9.5%	71.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11423.0%	-3940.7%
Net Margin (TTM)	-10132.0%	-4376.0%
FCF Margin (TTM)	-12323.0%	-4254.7%
Net Income (TTM)	$-10M	$-13M
FCF (TTM)	$-12M	$-13M
EPS (TTM)	-$1.11	-$0.29
ROE (TTM)	-7510.0%	-9349.0%
ROA (TTM)	-6015.0%	-3269.0%
ROIC (TTM)	-7510.0%	-8231.0%
Financial Health
Cash	$10M	$11M
Debt	$0	$2M
Net Cash/Debt	$10M	$10M
Current Ratio (TTM)	3.69x	1.13x
Quick Ratio (TTM)	3.50x	1.09x
Debt/Equity (TTM)	0.00x	0.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	1.25
52W Performance	-58.1%	-51.8%
YTD Performance	-45.9%	-16.5%
% from 52W High	-79.1%	-74.8%
% from 52W Low	7.3%	35.6%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.01x
FCF Yield (TTM)	-127.6%	-128.2%
Earnings Yield (TTM)	-104.9%	-131.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-12,413.7	-4,254.7
EV/GP/RG	N/A	0.00
Ticker research	View LSTA research	View TOVX research